Pipeline

Keticap Oral Capsules® development pipeline

Our company vision is to have a convenient medication proven to be effective against a range of indications which currently have a high unmet need.

Pipeline View.

Product/Indication
Phase I
Phase II
Phase III
Status
Product/Indication
Keticap Oral Capsules®
Treatment Resistant Depression
Phase I
Phase II
Phase III
Status
Suitable for Phase III submission with MHRA
Product/Indication
Keticap Oral Capsules®
Bipolar Depression
Phase I
Phase II
Phase III
Status
Study to commence in 2024
Product/Indication
Keticap Oral Capsules®
Anorexia – Depression
Phase I
Phase II
Phase III
Status
Under Consideration for Collaborative Development

Clinical Indications.

Brain key icon

Depression

Depression is one of the most prevalent mental health disorders, affecting around one in six adults. It can also be known as major depression, major depressive disorder, or clinical depression and is a common but serious mood disorder. It causes severe symptoms that affect how a person feels, thinks, and handles daily activities, such as sleeping, eating, or working.

Head with up and down arrow icon

Bipolar Depression

Bipolar depression episodes occur in patients with bipolar disorder, and these episodes of lowered mood can prevent the patient from carrying out day-to-day tasks. Bipolar depression can be fairly common and few treatment options are available to address these episodes.